Lawsuit concerns Teva's application for approval to market Levitra for the treatment of erectile dysfunction
Multaq to treat patients with atrial fibrillation or atrial flutter
Calls for shutdown of a number of manufacturing assets, including ethylene and ethylene-derivative assets
Myriad Genetics to claim approximately $400 million in tax deductions
Business comprises a portfolio of 13 branded pharmaceuticals
Acorda to continue developing and commercializing Fampridine-SR in the US
Graceway to acquire worldwide commercial rights for three investigational dermatological molecules from Pfizer
To develop therapeutic monoclonal antibodies for treatment of various forms of cancer and infectious disease
SEP-225289 did not meet the primary efficacy endpoint, but Lunesta has been proven to be safe and well tolerated
Vyvanse improved the ability to focus and organize, as well as hyperactivity and impulsivity
Corifollitropin Alfa provides treatment in Controlled Ovarian Stimulation for development of multiple follicles in women
